Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Colorcon
Chubb
Daiichi Sankyo
Argus Health
Healthtrust
Boehringer Ingelheim
Moodys
Cantor Fitzgerald

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021505

« Back to Dashboard

NDA 021505 describes KEPPRA, which is a drug marketed by Ucb Inc and is included in four NDAs. It is available from five suppliers. There are two patents protecting this drug and three Paragraph IV challenges. Additional details are available on the KEPPRA profile page.

The generic ingredient in KEPPRA is levetiracetam. There are thirty-five drug master file entries for this compound. Ninety-four suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 021505
Tradename:KEPPRA
Applicant:Ucb Inc
Ingredient:levetiracetam
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Pharmacology for NDA: 021505
Suppliers and Packaging for NDA: 021505
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KEPPRA levetiracetam SOLUTION;ORAL 021505 NDA UCB, Inc. 50474-001 N 50474-001-48

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength100MG/ML
Approval Date:Jul 15, 2003TE:AARLD:Yes

Expired US Patents for NDA 021505

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc KEPPRA levetiracetam SOLUTION;ORAL 021505-001 Jul 15, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc KEPPRA levetiracetam SOLUTION;ORAL 021505-001 Jul 15, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Fuji
Covington
Chinese Patent Office
AstraZeneca
Fish and Richardson
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.